Neoadjuvant chemoradiotherapy was associated with better survival in locally advanced gastric cancer
Neoadjuvant chemoradiotherapy achieved 26.5% pathological complete response and 80.4% five-year survival, outperforming chemotherapy-based strategies in this retrospective cohort.